- Regulation
- Technology
- Resources
Latest News
- Industry
-
HHS agency signals drug rebate program redux with request for information
The RFI is the Trump administration’s next move to get its drug pricing rebate program back on track after hospital groups blocked it last year.
-
Insurance executive and marketing CEO sentenced in $233m ACA fraud scheme
Texts exchanged by the defendants revealed a scheme that targeted low-income individuals experiencing homelessness, unemployment, and other challenges.
-
GRIP Extra: SEC proposes N-PORT scalebacks, OCC proposes appeals board
Our in-brief roundup of notable stories from the last week.
-
Calls for swift regulation of Brazilian butt lifts and injectables
Unsafe procedures raise health concerns and lead to major NHS expense for corrective surgeries.
-
![What [the heck] is going on with vaccine policy in America?](https://www.grip.globalrelay.com/wp-content/uploads/2026/02/G-Vaccine-signage-2259640793.jpg?w=1024)
What [the heck] is going on with vaccine policy in America?
Our experts argue that the government’s new approach could stymie R&D and brings uncertainty to the business of producing and offering vaccines.
-
FDA swiftly reverses RTF decision on Moderna flu shot candidate
The regulator is allowing the pharma giant’s revised biologics licensed application to proceed to review.
-
RTF flu vaccine letter heard around the world
The FDA issued an extremely rare refuse-to-file letter related to Moderna’s new mRNA flu vaccine.
-
FCA Healthcare roundup: Three cases of Medicare and Medicaid fraud in IL, MN, NY
Our in-brief, biweekly roundup of notable US Department of Justice False Claims Act cases related to healthcare fraud.